Literature DB >> 9628802

Involvement of TNF alpha, IL-1 beta and IL-1 receptor antagonist in LPS-induced rabbit uveitis.

J S Mo1, A Matsukawa, S Ohkawara, M Yoshinaga.   

Abstract

The objective of the study was to investigate involvement of TNF alpha, IL-1 beta and IL-1 receptor antagonist (IL-1Ra) in lipopolysaccharide (LPS)-induced uveitis. Intravitreal injection of LPS (100 ng) to rabbits induced a massive leukocyte infiltration and protein leakage into the aqueous humor. Aqueous leukocyte counts and protein levels reached a peak 24 hr after this injection. The peak concentrations of aqueous TNF alpha (230 +/- 37 pg ml-1, at 9 hr) and IL-1 beta (185 +/- 80 pg ml-1, at 18 hr) preceded peak levels of aqueous leukocyte counts and protein levels. In contrast, the levels of aqueous IL-1Ra peaked at 48 hr (12,239 +/- 1964 pg ml-1) and a fairly high concentration of IL-1Ra remained when the inflammatory reactions subsided. Immunohistochemistry and leukocyte-depletion studies showed that infiltrating leukocytes were the major cellular sources of aqueous TNF alpha, IL-1 beta and IL-1Ra. Intravitreal injection of homologous TNF alpha (0.1-1.5 micrograms) or IL-1 beta (0.5-5 ng) reproduced a rapid leukocyte infiltration and protein leakage. Administration of anti-TNF alpha mAb (10 micrograms) suppressed the number of LPS-induced infiltrating neutrophils by 50%, mononuclear cells by 58%, and protein leakage by 42%. Administration of rabbit IL-1Ra (10 micrograms) also suppressed neutrophil influx by 78%, however, neither mononuclear cell influx nor protein leakage was inhibited by rabbit IL-1Ra. Co-administration of the two inhibitors enhanced inhibition of neutrophil infiltration to 88%, and protein leakage to 64%. We conclude that TNF alpha and IL-1 beta are the principal mediators of LPS-induced uveitis. Our observations also suggest that endogenous IL-1Ra may down-regulate inflammatory reactions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9628802     DOI: 10.1006/exer.1997.0451

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  14 in total

Review 1.  Non-infectious pediatric uveitis: an update on immunomodulatory management.

Authors:  Srilakshmi M Sharma; Andrew D Dick; Athimalaipet V Ramanan
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

2.  Neutrophil accumulation correlates with type IV collagenase/gelatinase activity in endotoxin induced uveitis.

Authors:  C Cuello; D Wakefield; N Di Girolamo
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

3.  Gene therapy with the caspase activation and recruitment domain reduces the ocular inflammatory response.

Authors:  Cristhian J Ildefonso; Henrique Jaime; Manas R Biswal; Shannon E Boye; Qiuhong Li; William W Hauswirth; Alfred S Lewin
Journal:  Mol Ther       Date:  2015-02-20       Impact factor: 11.454

4.  Effects of proinflammatory cytokines on the claudin-19 rich tight junctions of human retinal pigment epithelium.

Authors:  Shaomin Peng; Geliang Gan; Veena S Rao; Ron A Adelman; Lawrence J Rizzolo
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-27       Impact factor: 4.799

5.  NAD(P)H oxidase-dependent regulation of CCL2 production during retinal inflammation.

Authors:  Wenbo Zhang; Modesto Rojas; Brenda Lilly; Nai-Tse Tsai; Tahira Lemtalsi; Gregory I Liou; Robert W Caldwell; Ruth B Caldwell
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02-21       Impact factor: 4.799

Review 6.  Biologic agents in experimental autoimmune uveitis.

Authors:  Gian Paolo Giuliari; Ama Sadaka; David M Hinkle
Journal:  Int Ophthalmol       Date:  2013-03-14       Impact factor: 2.031

7.  Activation of NOD2 in vivo induces IL-1beta production in the eye via caspase-1 but results in ocular inflammation independently of IL-1 signaling.

Authors:  H L Rosenzweig; T M Martin; S R Planck; K Galster; M M Jann; M P Davey; K Kobayashi; R A Flavell; J T Rosenbaum
Journal:  J Leukoc Biol       Date:  2008-05-21       Impact factor: 4.962

8.  Antioxidant properties of lutein contribute to the protection against lipopolysaccharide-induced uveitis in mice.

Authors:  Rong-Rong He; Bun Tsoi; Fang Lan; Nan Yao; Xin-Sheng Yao; Hiroshi Kurihara
Journal:  Chin Med       Date:  2011-10-31       Impact factor: 5.455

9.  Suppression of experimental uveitis by a recombinant adeno-associated virus vector encoding interleukin-1 receptor antagonist.

Authors:  Ming-Ling Tsai; Chi-Ting Horng; Show-Li Chen; Xiao Xiao; Chih-Hung Wang; Yeou-Ping Tsao
Journal:  Mol Vis       Date:  2009-08-08       Impact factor: 2.367

Review 10.  Profile of adalimumab and its potential in the treatment of uveitis.

Authors:  Stephen J Balevic; C Egla Rabinovich
Journal:  Drug Des Devel Ther       Date:  2016-09-19       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.